Literature DB >> 15156335

Congenital diaphragmatic hernia: a survey of practice in Scandinavia.

Hans Skari1, Kristin Bjornland, Bjorn Frenckner, Lars Goran Friberg, Marja Heikkinen, Timo Hurme, Borger Loe, Gunnhild Mollerlokken, Ole Henrik Nielsen, Niels Qvist, Risto Rintala, Katarina Sandgren, Willy Serlo, Kari Wagner, Tomas Wester, Ragnhild Emblem.   

Abstract

There is no consensus on the treatment of congenital diaphragmatic hernia (CDH), and practice seems to vary between centres. The main purpose of the present study was to survey current practice in Scandinavia. Thirteen paediatric surgical centres serving a population of about 22 million were invited, and all participated. One questionnaire was completed at each centre. The questionnaire evaluated management following prenatal diagnosis, intensive care strategies, operative treatment, and long-term follow-up. Survival data (1995-1998) were available from 12 of 13 centres. Following prenatal diagnosis of CDH, vaginal delivery and maternal steroids were used at eight and six centres, respectively. All centres used high-frequency oscillation ventilation (HFOV), nitric oxide (NO), and surfactant comparatively often. Five centres had extracorporeal membrane oxygenation (ECMO) facilities, and four centres transferred ECMO candidates. The majority of centres (7/9) always tried HFOV before ECMO was instituted. Surgery was performed when the neonate was clinically stable (11/13) and when no signs of pulmonary hypertension were detected by echo-Doppler (6/13). The repair was performed by laparotomy at all centres and most commonly with nonabsorbable sutures (8/13). Thoracic drain was used routinely at seven centres. Long-term follow-up at a paediatric surgical centre was uncommon (3/13). Only three centres treated more than five CDH patients per year. Comparing survival in centres treating more than five with those treating five or fewer CDH patients per year, there was a tendency towards better survival in the higher-volume centres (72.4%) than in the centres with lower volume (58.7%), p =0.065.

Entities:  

Mesh:

Year:  2004        PMID: 15156335     DOI: 10.1007/s00383-004-1186-7

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  35 in total

1.  Is delayed surgery really better for congenital diaphragmatic hernia?: a prospective randomized clinical trial.

Authors:  M N de la Hunt; N Madden; J E Scott; J N Matthews; J Beck; C Sadler; A M Barrett; S A Boddy; R J Bray; E Cusick; L Gardner; S A Hargrave; W Hinton; L Rangecroft; R Spicer; M Stafford; D Thomas; C J Vallis; J Wagget
Journal:  J Pediatr Surg       Date:  1996-11       Impact factor: 2.545

Review 2.  Late versus early surgical correction for congenital diaphragmatic hernia in newborn infants.

Authors:  V Moyer; F Moya; R Tibboel; P Losty; M Nagaya; K P Lally
Journal:  Cochrane Database Syst Rev       Date:  2000

3.  Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group.

Authors:  R H Clark; T J Kueser; M W Walker; W M Southgate; J L Huckaby; J A Perez; B J Roy; M Keszler; J P Kinsella
Journal:  N Engl J Med       Date:  2000-02-17       Impact factor: 91.245

4.  A cost-effectiveness analysis of the application of nitric oxide versus oxygen gas for near-term newborns with respiratory failure: results from a Canadian randomized clinical trial.

Authors:  P Jacobs; N N Finer; C M Robertson; P Etches; E M Hall; L D Saunders
Journal:  Crit Care Med       Date:  2000-03       Impact factor: 7.598

5.  Antenatal betamethasone and favourable outcomes in fetuses with 'poor prognosis' diaphragmatic hernia.

Authors:  W D A Ford; C P Kirby; C S Wilkinson; M E Furness; A J Slater
Journal:  Pediatr Surg Int       Date:  2002-05       Impact factor: 1.827

6.  Improved results in patients who have congenital diaphragmatic hernia using preoperative stabilization, extracorporeal membrane oxygenation, and delayed surgery.

Authors:  B Frenckner; H Ehrén; T Granholm; V Lindén; K Palmér
Journal:  J Pediatr Surg       Date:  1997-08       Impact factor: 2.545

7.  Administration of antenatal glucocorticoids prevents pulmonary artery structural changes in nitrofen-induced congenital diaphragmatic hernia in rats.

Authors:  Y Taira; E Miyazaki; K Ohshiro; T Yamataka; P Puri
Journal:  J Pediatr Surg       Date:  1998-07       Impact factor: 2.545

8.  Congenital diaphragmatic hernia--a tale of two cities: the Toronto experience.

Authors:  K Azarow; A Messineo; R Pearl; R Filler; G Barker; D Bohn
Journal:  J Pediatr Surg       Date:  1997-03       Impact factor: 2.545

9.  Congenital diaphragmatic hernia: developing a protocolized approach.

Authors:  N N Finer; A Tierney; P C Etches; A Peliowski; W Ainsworth
Journal:  J Pediatr Surg       Date:  1998-09       Impact factor: 2.545

Review 10.  Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants.

Authors:  Miranda Mugford; Diana Elbourne; David Field
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16
View more
  4 in total

1.  Self-assessed physical health among children with congenital diaphragmatic hernia.

Authors:  Elin Öst; Maria Öjmyr Joelsson; Carmen Mesas Burgos; Björn Frenckner
Journal:  Pediatr Surg Int       Date:  2016-02-24       Impact factor: 1.827

Review 2.  Recent advances in congenital diaphragmatic hernia.

Authors:  N P Smith; E C Jesudason; N C Featherstone; H J Corbett; P D Losty
Journal:  Arch Dis Child       Date:  2005-04       Impact factor: 3.791

3.  Congenital diaphragmatic hernia: onset of respiratory distress and size of the defect: analysis of the outcome in 104 neonates.

Authors:  Michal Rygl; K Pycha; Z Stranak; J Melichar; L Krofta; L Tomasek; J Snajdauf
Journal:  Pediatr Surg Int       Date:  2006-09-22       Impact factor: 1.827

4.  Evaluation of congenital diaphragmatic hernia in a tertiary health center of a developing country: management and survival.

Authors:  A Pandey; R K Tandon; S N Kureel; A Wakhlu; J Rawat
Journal:  Hernia       Date:  2007-11-15       Impact factor: 4.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.